Europe Small Molecule Drug Delivery Market to Grow at a CAGR of 9.0% to reach US$ 13,381.71 Million from 2020 to 2027

Europe Small Molecule Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Country Analysis - by Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas); Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Country

Publication Month: Aug 2020 | Report Code: TIPRE00013000 | No. of Pages: 138 | Category: Pharmaceuticals | Status: Published
Covid

Europe small molecule drug delivery market is expected to reach US$ 13,381.71 million by 2027 from US$ 6,835.97 million in 2019. The market is anticipated to grow with a CAGR of 9.0% from 2020 to 2027.

 

Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities that are capable of specific interactions represents a significant challenge in the early stages of drug discovery.

 

Germany Small Molecule Drug Delivery Market Revenue and Forecast to 2027 (US$ Million)
Germany Small Molecule Drug Delivery Market Revenue and Forecast to 2027 (US$ Million)

Get more information on this report :


 


Market Insights

Growing Developments and Start-Ups in Small Molecules Drug Delivery Market

Small molecules offer innovative medications for the four significant indications, such as oncology, diabetes, autoimmune, and respiratory diseases. For instance, combination with large molecules as antibody-drug conjugates (ADC), allowing more precise treatment of cancer. Additionally, small molecule protein kinase inhibitors are becoming increasingly important in cancer therapy. This has led to increasing product approvals of small molecule drugs and growing number of start-up companies, which are the prime factors for the growth of the small molecule drug discovery market.

Hungray based ChemPass founded in 2016, generate molecular structures based on user-defined criteria. It design novel small organic molecules and scaffolds. Additionally, Molomics headquarter in Barcelona, Catalonia, Spain uses artificial intelligence (AI) in drug discovery to design structurally new small molecules for validated biological targets. This allows researchers to collaborate with each other (using what they call "Human Collective Intelligence") and AI to jointly develop safer and more effective therapeutics. Owing to above mentioned factors, the market for small molecule drug delivery is likely to grow in the forecasted period.

 

Therapeutic Type- Based Market Insights

Based on therapeutic type, the small molecule drug delivery market is further segmented into oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology, rare diseases, and other therapeutic areas. The oncology segment held the largest share of the market in 2019, however, rare diseases is anticipated to register the highest CAGR in the market during the forecast period.

 

Europe Small Molecule Drug Delivery Market, by Therapeutic Type– 2019 and 2027

 

 

Process/Phase -Based Market Insights

Based on process/phase, the small molecule drug delivery market is segmented into target discovery, target validation, lead generation and refinement, and preclinical development. The lead generation and refinement segment held the largest share of the market in 2019. Moreover, target discovery is estimated to register the highest CAGR during the forecast period.

 

Strategic Insights

Product launches and approvals are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the small molecule drug delivery market adopt the expansion, collaboration, and product launch strategies to enlarge customer base across the world. These strategies allow the players to maintain their brand name globally. For instance, in May 2018, Cloud Pharmaceuticals, Inc., an AI-driven drug design and development company, entered into drug discovery collaboration with GlaxoSmithKline (GSK), wherein Cloud will bedesigning novel small-molecule agents for GSK specified targets through its proprietary AI-driven process to design the molecules.

 

By Therapeutic Area

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Orthopedics
  • Immunology
  • Rare Diseases
  • Other Therapeutic Areas

By Process/Phase

  • Target Discovery
  • Target Validation
  • Lead Generation and Refinement
  • Preclinical Development

By Country

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

 

Company Profiles

  • Merck KGaA
  • GlaxoSmithKline plc
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Allergan Plc
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd

TABLE OF CONTENTS

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe Small Molecule Drug Discovery Market – By Therapeutic Area

1.3.2        Europe Small Molecule Drug Discovery Market – By Process/Phase

1.3.3        Europe Small Molecule Drug Delivery Market– By Region

2.          Small Molecule Drug Delivery Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Small Molecule Drug Delivery – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Europe

4.3        Expert Opinion

5.          Europe Small Molecule Drug Delivery Market – Industry Dynamics

5.1        Key Drivers

5.1.1        Growing Demand for R&D from Contract Organizations

5.1.2        Growing Developments and Start-Ups in Small Molecules Drug Delivery Market

5.2        Market Restraints

5.2.1        High Cost of Drug Development

5.3        Market Opportunities

5.3.1        Growing Small Molecule Drug Delivery Product Approvals and Collaborations

5.4        Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5        Impact analysis

6.          Small Molecule Drug Delivery Market – Regional Analysis

6.1        Europe Small Molecule Drug Delivery Market Revenue Forecast And Analysis

6.2        Market Positioning of Key Players

7.          Small Molecule Drug Discovery Market–  By Therapeutic Area

7.1        Overview

7.2        Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)

7.3        Oncology

7.3.1        Overview

7.3.2        Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.4        Central Nervous System

7.4.1        Overview

7.4.2        Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027  (US$ million)

7.5        Cardiovascular

7.5.1        Overview

7.5.2        Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.6        Respiratory

7.6.1        Overview

7.6.2        Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.7        Orthopedics

7.7.1        Overview

7.7.2        Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.8        Immunology

7.8.1        Overview

7.8.2        Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.9        Rare Diseases

7.9.1        Overview

7.9.2        Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

7.10     Other Therapeutic Areas

7.10.1     Overview

7.10.2     Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027  (US$ million)

8.          Small Molecule Drug Discovery Market –  By Process/Phase

8.1        Overview

8.2        Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)

8.3        Target Discovery

8.3.1        Overview

8.3.2        Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.4        Target Validation

8.4.1        Overview

8.4.2        Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.5        Lead Generation and Refinement

8.5.1        Overview

8.5.2        Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.6        Preclinical Development

8.6.1        Overview

8.6.2        Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027  (US$ Million)

9.          Small Molecule Drug Discovery Market – Geographic Analysis

9.1        Europe: Small Molecule Drug Discovery Market

9.1.1        Overview

9.1.2        Europe: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Millions)

9.1.3        Europe: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018–2027 (USD Millions)

9.1.4        Europe: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5        Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

9.1.5.1         Germany: Small Molecule Drug Discovery Market

9.1.5.1.1         Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.1.2         Germany: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.1.3         Germany: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5.2         United Kingdom: Small Molecule Drug Discovery Market

9.1.5.2.1         United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.2.2         United Kingdom: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.2.3         United Kingdom: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5.3         France: Small Molecule Drug Discovery Market

9.1.5.3.1         France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.3.2         France: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.3.3         France: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5.4         Italy: Small Molecule Drug Discovery Market

9.1.5.4.1         Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.4.2         Italy: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.4.3         Italy: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

9.1.5.5         Spain: Small Molecule Drug Discovery Market

9.1.5.5.1         Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)

9.1.5.5.2         Spain: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)

9.1.5.5.3         Spain: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)

10.       Impact Of COVID-19 Pandemic On Europe Small Molecule Drug Delivery Market

10.1     Europe: Impact Assessment of COVID-19 Pandemic

11.       Small Molecule Drug Discovery Market –Company Profiles

11.1     Merck KGaA

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2     GlaxoSmithKline plc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3     AstraZeneca

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4     Boehringer Ingelheim International GmbH

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5     Allergan Plc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.       Appendix

12.1     About The Insight Partners

12.2     Glossary of Terms

 


LIST OF TABLES

Table 1.            Europe Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 2.            Europe Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 3.            Germany Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 ( USD Millions)

Table 4.            Germany Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 5.            United Kingdom Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)

Table 6.            United Kingdom Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 7.            France Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 8.            France Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027  (USD Millions)

Table 9.            Italy Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)

Table 10.         Italy Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 11.         Spain Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027  (USD Millions)

Table 12.         Spain Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)

Table 13.         Glossary of Terms, Small Molecule Drug Discovery Market

 


LIST OF FIGURES

Figure 1.          Small Molecule Drug Delivery Market Segmentation

Figure 2.          Small Molecule Drug Delivery Segmentation – By Region

Figure 3.          Europe Small Molecule Drug Delivery Market Overview

Figure 4.          The Oncology Segment Held Largest Share and Rare Diseases Segment Expected To Grow With Highest Growth Rate

Figure 5.          Germany Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.          Europe PEST Analysis

Figure 7.          Small molecule drug discovery Market Impact Analysis of Driver and Restraints

Figure 8.          Europe Small Molecule Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027

Figure 9.          Market Positioning of Key Players In Europe Small Molecule Drug Discovery Market

Figure 10.        Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)

Figure 11.        Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 12.        Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 13.        Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 14.        Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 15.        Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 16.        Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 17.        Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 18.        Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)

Figure 19.        Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)

Figure 20.        Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Europe: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Millions)

Figure 25.        EuropeSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 26.        Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)

Figure 27.        Germany Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 28.        United KingdomSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 29.        FranceSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 30.        ItalySmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 31.        SpainSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)

Figure 32.        Impact of COVID-19 Pandemic In European Country Markets

  1. Merck KGaA
  2. GlaxoSmithKline plc
  3. AstraZeneca
  4. Boehringer Ingelheim International GmbH
  5. Allergan Plc
  6. Pfizer Inc.
  7. Bristol-Myers Squibb Company
  8. Johnson & Johnson Services, Inc.
  9. Teva Pharmaceutical Industries Ltd
  • To understand the Europe small molecule drug delivery market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe small molecule drug delivery market
  • Efficiently plan M&A and partnership deals in Europe small molecule drug delivery market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of Europe small molecule drug delivery market.
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe
TIPRE00013000
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing